VP, Digital Transformation & Tech Enabling Services
Strateos, Inc., California, United States
Daniel has more than 20 years of experience in the biopharma industry, working across multiple functional disciplines, including phenotypic assay development, high-throughput screening, and software engineering. Before Strateos, he was a Research Investigator at Novartis (GNF) and led multiple drug discovery campaigns. His research focused on developing novel phenotypic assays across various indications. Daniel received a B.S. in Biochemistry from the University of California at Davis and a Ph.D. in Cell and Molecular Biology from the Massachusetts Institute of Technology (MIT).
Disclosure information not submitted.
Monday, February 7, 2022
4:30 PM – 5:30 PM
Tuesday, February 8, 2022
2:30 PM – 4:00 PM